Aprea Therapeutics

$5.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-9.64%) Today
+$0.03 (+0.60%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell APRE and other stocks, options, and ETFs commission-free!

About APRE

Aprea Therapeutics, Inc. Common stock, also called Aprea Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics.

CEO
Christian S. Schade
Employees
—
Headquarters
Boston, Massachusetts
Founded
2002
Market Cap
95.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.88M
High Today
$5.41
Low Today
$4.93
Open Price
$5.31
Volume
1.85M
52 Week High
$41.12
52 Week Low
$4.64

APRE Earnings

-$5.29
-$3.53
-$1.76
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 14, After Hours

You May Also Like

JHCS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure